What are the long-term side effects of Mounjaro to weigh up before starting?

Most recorded side effects are gastrointestinal and are most noticeable at the start of treatment or after a dose increase, typically easing within a couple of weeks.
Pancreatitis is a rare but serious risk: in January 2026 the MHRA issued a Drug Safety Update specifically highlighting acute pancreatitis across all GLP-1 medicines, including tirzepatide.
Long-term effects on lean muscle mass, bone density and thyroid tissue are active areas of clinical monitoring; no definitive causal harm has been established in humans for the latter two.
Any suspected side effect (common or unusual) can be reported directly to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk.

The long-term side effects of Mounjaro (tirzepatide) are still being studied, because the medicine has only been in widespread use for weight management since 2023. What the evidence gathered so far shows is that most side effects are gastrointestinal, tend to peak in the early weeks of treatment, and often settle — but a small number of effects deserve careful, ongoing monitoring over months or years. Mounjaro is a prescription-only medicine; a clinician reviews your health history before it is prescribed, and that clinical relationship continues throughout treatment.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the current evidence says about Mounjaro's effects over months and years

The decision most people are actually making: short-term discomfort versus long-term unknowns

When someone asks about long-term side effects of Mounjaro, they are usually weighing two things against each other. On one side: the real, well-documented health risks of living with obesity over years — cardiovascular disease, type 2 diabetes, joint damage, sleep apnoea. On the other: the question of what staying on a relatively new medicine for a year or more might do to the body in ways that clinical trials, running for 72 weeks or so, cannot fully answer yet.

That is a reasonable thing to think through, and it deserves a straight answer rather than reassurance. The honest position is this: the short- and medium-term profile of tirzepatide is well-characterised across thousands of trial participants. The very long-term picture (what happens after five or ten years of continuous use) is not yet known, because the medicine simply has not been in use that long at population scale. Ongoing post-marketing surveillance is gathering that data now.

The NHS patient information for tirzepatide covers the recognised side effects with clear practical guidance. Reading it alongside a conversation with your prescriber is the right starting point, not a substitute for it. Our prescribers at nume's Mounjaro service discuss side effect history and individual risk factors as part of every consultation.

What is well-established: the side-effect profile across the trial period

The clearest picture comes from the SURMOUNT-1 trial (72 weeks, tirzepatide vs placebo, involving 2,539 adults with obesity) and the ongoing pharmacovigilance data gathered since UK licensing in 2023. Gastrointestinal effects dominate: nausea, loose stools, constipation, acid reflux, and a general feeling of fullness that some people find uncomfortable. These are most pronounced in the first few weeks and after each upward dose step. For most people they reduce significantly once the body adjusts.

Fatigue, headache, and injection-site reactions (mild redness or discomfort where the pen is used) are also commonly reported. Tirzepatide slows gastric emptying as part of its mechanism, which is why GI effects are so central to its profile. If you want to understand what side effects to expect when taking Mounjaro, knowing this in advance helps: eating smaller portions, keeping meals lower in fat, staying well hydrated, and not eating right up to bedtime all reduce the burden noticeably.

The full risk profile of Mounjaro includes less common effects too, such as mild hair thinning (telogen effluvium, linked to rapid weight loss rather than the medicine itself), raised heart rate, and gallbladder-related symptoms. Gallstones can form during significant weight loss on any treatment, this is worth discussing with a prescriber, particularly if you have a personal or family history of gallbladder problems.

When to get medical help, and the side effects that need urgent attention

A few potential effects require prompt action rather than watchful waiting. Pancreatitis is the most serious. In January 2026, following a review of real-world case reports, the MHRA published a Drug Safety Update confirming acute pancreatitis as a known risk across GLP-1 medicines including tirzepatide. The symptom to act on is severe, persistent stomach pain that spreads to your back, with or without vomiting. Stop the medicine and seek urgent medical attention if that happens, do not wait for your next scheduled review.

Other situations that need prompt medical contact: signs of a serious allergic reaction (swelling of the face, lips or throat; difficulty breathing; severe rash); symptoms of severe dehydration following prolonged vomiting or diarrhoea (very little urine, dizziness, rapid heartbeat); and any sudden unexplained changes in vision. If you are using Mounjaro alongside insulin or a sulphonylurea for diabetes, low blood sugar is an additional risk to know the signs of.

For a broader picture of the side-effect landscape, our guide to what the side effects of Mounjaro are covers frequency, management, and when each symptom typically appears. And if something feels wrong between scheduled reviews, our aftercare team is available seven days a week.

The longer-horizon questions: muscle, bone, and thyroid

Three areas draw the most clinical interest when researchers look beyond the trial window. First, lean muscle loss. Rapid weight loss of any kind (dietary or medicine-assisted) can reduce muscle alongside fat. Current guidance suggests pairing treatment with adequate protein intake and resistance-based activity to preserve muscle mass; your prescriber can advise on this specifically. Second, bone density. There is some signal in the broader GLP-1 data that rapid weight loss may affect bone mineral density over time, though no firm causal link has been established for tirzepatide specifically. Third, thyroid: in animal studies, GLP-1 receptor agonists showed an association with thyroid C-cell tumours. This has not been replicated in human data, but people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 should not take tirzepatide, it is a contraindication, not a precaution.

These are not reasons to rule tirzepatide out; they are reasons why the clinical relationship matters throughout treatment, not just at the start. A prescriber who knows your history (including bone health, thyroid conditions, and activity level) is placed to monitor what needs monitoring, and our page on whether there are any long-term side effects of Mounjaro goes into this in more detail. If you are considering treatment and want to understand whether Mounjaro has long-term side effects beyond the trial window, that question is covered in full on the site. If you are considering treatment and want to understand how our clinical oversight works, that information is on the site. When you are ready to talk through your own situation, check your eligibility with a free consultation and our prescribers will go through suitability and side effects with you directly.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions